natural-biocon-india-ltd

Natural Biocon (India) Ltd Financials
Company Logo

Natural Biocon (India) Ltd Financial Statement

Natural Biocon (India) Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Sep 2024
Revenue4.74
Operating Expense4.53
Net Profit0.20
Net Profit Margin4.22
Earning Per Share0.08
EBIDTA0.20
Effective Tax RateTBA

Natural Biocon (India) Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual13.53
Operating Expenses Annual13.31
Operating Profit Annual0.23
Interest AnnualTBA
DepreciationTBA
Net Profit Annual0.15
Tax Annual0.07

Natural Biocon (India) Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning0.40
Cash Flow from Operations-0.12
Cash Flow from InvestingTBA
Cash Flow from Financing-0.09
Cash Flow at the End0.19

Natural Biocon (India) Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)1.70
PBIT Margin (%)1.70
PBT Margin (%)1.70
Net PROFIT Margin (%)1.11
Return On Networth / Equity (%)1.22
Return On Networth /Employed (%)1.77
Return On Assets (%)1.21
Total Debt / Equity (X)0.01
Asset Turnover Ratio (%)1.09

Natural Biocon (India) Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual0.01
Total Current Assets Annual5.40
Non Current Assets Annual11.37
Total Shareholders Funds Annual12.38
Total Assets Annual16.77

Natural Biocon (India) Ltd Earning Calls

No Data Availabe

Get Your FAQs Right

As of Dec 13, 2024, Natural Biocon (India) Ltd has a market capitalization of 11.61 Cr. Value Research classifies it as a Micro-Cap company.
Yes, Natural Biocon (India) Ltd is debt-free with a debt-to-equity ratio of 0.01.
In FY 2023 , Natural Biocon (India) Ltd recorded a total revenue of approximately 13.53 Cr marking a significant milestone in the company's financial performance.
Natural Biocon (India) Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.1% and 1.7% annually, respectively..
Natural Biocon (India) Ltd's current PE ratio is 77.40.
Natural Biocon (India) Ltd's ROCE averaged 1.5% from the FY ending March 2022 to 2024, with a median of 1.8%. It peaked at 2.0% in March 2023, reflecting strong capital efficiency over the period..
Natural Biocon (India) Ltd's latest EBIT is Rs. 0.23 Cr, surpassing the average EBIT of Rs. 0.19 Cr over the 5 years..
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions